Menu

Kindred Biosciences, Inc. KIN

Full chart Compare
Set alert

Price alert · KIN

All alert types
9.25 +9.25

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue by
Asset Sale → Revenue: $38.70MRevenue → Gross Profit: $37.54MGross Profit → Expenses: $37.54MRevenue → Cost of Revenue: $4.63MExpenses → Selling, General & Admin: $21.98MExpenses → Research & Development: $31.28MExpenses → Interest Expense: $1.83MExpenses → Other Expenses: $4.25MExpenses → Income Tax: $1.83MNet Loss → Expenses: $23.62MManufacturing → Revenue: $1.55MProduct Revenue → Revenue: $878.00KRoyalty → Revenue: $535.00KPartner Licensing → Revenue: $500.00KGross Profit$37.54MNet Loss$23.62MCost of Revenue$4.63MExpenses$61.16MSelling, General & Admin$21.98MResearch & Development$31.28MInterest Expense$1.83MOther Expenses$4.25MIncome Tax$1.83MRevenue$42.16MAsset Sale$38.70MManufacturing$1.55MProduct Revenue$878.00KRoyalty$535.00KPartner Licensing$500.00K

Latest period ending Dec 31, 2020 · select a line to chart its full history

KIN annual income statement
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
42.16M4.26M1.97M00
37.54M3.67M1.64M00
-19.97M-62.57M-51.26M-31.65M-22.82M
-21.80M-61.39M-49.69M-30.88M-22.50M
-0.55-1.59-1.60-1.23-1.13
KIN annual balance sheet
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
11.62M15.99M56.30M34.81M6.69M
95.81M114.02M106.48M90.82M61.58M
28.33M32.10M15.28M6.14M3.90M
23.37M22.52M000
67.48M81.92M91.21M84.68M57.68M
KIN annual cash flow
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
-9.86M-56.34M-45.03M-21.88M-18.78M
5.77M-47.82M16.60M-2.67M5.31M
-282.00K63.84M49.92M52.67M162.00K
-3.56M-8.42M-13.67M-5.92M-952.00K
-4.37M-40.32M21.49M28.13M-13.30M